Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01445 (long intergenic non-protein coding RNA 1445) is a long intergenic non-coding RNA (lincRNA), which means it is a transcribed RNA molecule longer than 200 nucleotides and does not encode a protein. LincRNAs like LINC01445 are distinguished by their lack of protein-coding ability and their location outside of known protein-coding gene loci. As a member of the lncRNA transcript family, LINC01445 might participate in various regulatory functions such as chromatin and nuclear architecture remodeling, transcriptional regulation (acting locally or at a distance), and the modulation of gene expression with tissue specificity. However, the biological significance and precise tissue, cellular, or disease roles of LINC01445 itself remain uncharacterized in public reference databases and most peer-reviewed literature. Most lincRNAs, including LINC01445, are still under study for their functional relevance in cellular physiology and pathology.
Not applicable, since no drugs are known to target LINC01445.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1445 (LINC01445).